Atopic dermatitis or atopic eczema
is a chronic inflammatory skin disease characterized by itchy skin lesions and
rashes. Though the condition affects people of all ages, it is primarily common
among infants and children (Bowcock and Cookson, 2004). Due to its chronic and
relapsing nature, atopic dermatitis presents a global public health concern,
with reported lifetime prevalence ranging between 10%–20% in children and 1%–3%
in adults (Larsen and Hanifin, 2002). In general, the prevalence of atopic
dermatitis is increasing worldwide, with high prevalence in western and
developed nations compared with other parts of the world. However, recent
trends demonstrate a gradual rise in prevalence in developing countries and
plateauing prevalence in developed countries (Asher et al., 2006). Although
atopic dermatitis is not life-threatening, it has a huge impact on economic
burden and quality of life of individuals (Carroll et al., 2005).
To
Read The Complete Report with TOC : www.marketresearchreports.biz/analysis-details/epicast-report-atopic-dermatitis-epidemiology-forecast-to-2022
GlobalData’s epidemiological
analysis forecasts that prevalent cases of atopic dermatitis in the 9MM (US,
France, Germany, Italy, Spain, UK, Japan, China, and India) will increase from
132.28 million in 2012 to 132.71 million cases in 2022 at an annual growth rate
(AGR) of 0.10%. In 2012, China and India combined contributed 83.04 million
cases, comprising more than 60% of the total prevalent cases in the 9MM.
GlobalData’s epidemiological
forecast projects a substantial increase in the lifetime prevalent cases of
atopic dermatitis in the 9MM over the forecast period (2012–2022). As
GlobalData epidemiologists used steady prevalence proportions of atopic
dermatitis over the forecast period, the growth in prevalent cases in each
market can be attributed to the change in population demographics in the
respective markets, especially in the younger age groups as they comprise the
highest proportion of the prevalent cases.
The forecast underscores the
considerable psychosocial and economic burden inflicted by atopic dermatitis
particularly among children. Governments in the respective markets should
develop strategies to tackle the growing problem and direct appropriate
interventions towards reducing various triggers inducing atopic dermatitis
especially among young children (Williams et al., 2012).
Scope
- The Atopic Dermatitis EpiCast
Report and EpiCast Model provide an overview of the risk factors and
global trends of atopic dermatitis in the 9MM. It includes a 10-year
epidemiology forecast of atopic dermatitis prevalent cases segmented by
age (in five-year increments beginning at age 0 and ending at ages 85
years and older), sex, and severity (mild, moderate, and severe) in the
9MM.
Reasons To Buy
- Develop business strategies by
understanding the trends shaping and driving the global atopic dermatitis
market.
- Quantify patient populations in
the global atopic dermatitis market to improve product design, pricing,
and launch plans.
- Organize sales and marketing
efforts by identifying the age groups and sex that present the best
opportunities for atopic dermatitis therapeutics in each of the markets
covered.
- Identify the percentage of
atopic dermatitis prevalent cases that are mild, moderate, and severe.
About Us
MarketResearchReports.Biz is the
most comprehensive collection of market research reports.
MarketResearchReports.Biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs, our
main offerings are syndicated research reports, custom research, subscription
access and consulting services. We serve all sizes and types of companies
spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment